HJF Medical Research International

Participants at HJF Medical Research International in Abuja, Nigeria, have been vaccinated in the first Phase 2 clinical trial of a Lassa fever virus (LASV) vaccine candidate to date, according to IAVI, a nonprofit scientific research organization and the trial sponsor. The study (IAVI C105/PREVAIL15) is funded by CEPI, an innovative global partnership working to accelerate the development of vaccines against epidemic and pandemic threats. 

Maurice is one of many who have benefited from PEPFAR’s promise to deliver quality healthcare in remote communities through a mobile clinic outreach program. Before the mobile clinic, members of Maurice’s community would have to travel to Tanzania by foot - an eight-day journey in territory inhabited by wild animals and warring clans, to receive health services. “Some people would die there, and it was hard,” Maurice says. 

When Edith Okafor, a 50-year-old widow and caregiver of four boys, walked into the Clinical Training and Research Centre (CTRC), 44 Nigerian Army Reference Hospital Kaduna (NARHK) to begin antiretroviral therapy in April 2007, she had no idea that that encounter would become the beacon of hope in her state of despair.  

Geoffrey Mwakyusa (49), a resident of the Kyela District Council in the Mbeya Region, is among hundreds of thousands of people in the area who have connected with Community-based HIV Service Providers (CBHSP) to find out their HIV status through the distribution of HIV self-testing kits.

Ahead of the October 20 Mashujaa Day celebrations in Kericho, Kenya’s Deputy President H.E. Rigathi Gachagua, EGH, visited the Kericho, Kenya Medical Research Institute (KEMRI)/ Walter Reed Project (WRP) Clinical Research Center (CRC), where he inaugurated the biosafety level 3 tuberculosis (TB) Reference Laboratory. 

The African Cohort Study (AFRICOS) celebrated its 10th Anniversary on Wednesday 1st November, 2023, with a Research Symposium to review key findings from the study, share ongoing analyses, and discuss plans under the theme titled, “Progress and Future Directions.”

In 2007, Joyce, David and their two children were featured on the cover of PEPFAR’s annual report to Congress, but their story about how PEPFAR transformed their lives began in 2005. David and Joyce were expecting their second child in 2005 when David discovered he was living with HIV. The next day, David brought his wife, Joyce, to Kericho District Hospital to get tested.

September 28, 2023, marked a significant milestone, as HJF Medical Research International Ltd/Gte. (HJFMRI Ltd/Gte.) celebrated the grand opening of its new laboratories and office complex  in Abuja, Nigeria.

Deborah is one of the oldest stories of PEPFAR’s impact in Kenya and is a true testament to the purpose and mission of PEPFAR. More than 20 years ago, Deborah was diagnosed with HIV. 

HJFMRI helped coordinate entomology surveillance teams to quickly gather data in a race against emerging dengue and yellow fever outbreaks in Kenya.